Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LOW
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Bad
0%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -4.79 1.17 1.23
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -32.04 11.78 17.34
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.44 -25.58 -26.22
Cash 186.60 6.13 2.14
Capex 38.06 -0.67 -1.08
Free Cash Flow 699.26 6.80 0.85
Revenue 15.45 37.42 32.41
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 3.88 0.31 0.30
Operating Margin 30.80 0.12 0.09
ROA 64.44 0.04 0.02
ROE -77.29 -0.12 -0.07
ROIC 44.04 0.09 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LOW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LOW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LOW is permitted for members.